  WALL STREET STOCKS/MARION LABS <MKC>      NEW YORK, April 7 - Marion Laboratori Inc stock rose sharpli todai compani present bullish earn scenario meet pharmaceut analyst Monday, trader analyst said. 
    The compani expect earn fiscal 1987, end June 30, rise more 75 pct over year ago. 
    That pronounc encourag analyst David Crossen Sanford C. 
Bernstein Co rais earn estim compani 1.28 dlr share 1987, compar previou estim 1.20 dlr share. 
Last year compani earn 70 ct share. 
    Marion stock gain 3-1/4 75-1/2. 
    At meet pharmaceut analysts, Marion presid Fred Lyon Jr. 
Wall Street eanr estim 1.10-1.15 dlr share fiscal 1987 expect caus even aggress side rang 10 15 ct low. 
    Lyon strong perform second half year result fourth quarter introduct 90 mg 120 mg Cardizem tablets. 
Analyst Crossen Cardizem, treat angina, expect approv treatment hypertens end year. 
    Crossen Marion still small company, growth Cardizem have big impact bottom line. 
He rais fiscal 1988 earn estim 2.15 dlr share previou estim 2.05 dlr share. 
    The compani broad new product pipelin industri far I concerned, innov compani business, said. 
    For five year through 1991, Crossen expect Marion growth rate 55 pct.
